to the liver, adrenal glands, and abdominal lymph nodes. In a recent meta-analysis of the usefulness of the had been examined by abdominal ultrasonography.
Background -There is limited information available regarding the reStudies have examined the relationship between clinical signs indicating widespread dislationship between clinical indicators of widespread disease in patients with lung ease and the presence of abdominal metastases as assessed by computed tomographic (CT) cancer and the findings of transcutaneous ultrasonography. scanning [4] [5] [6] [7] [8] [9] [10] and isotopic scanning. [11] [12] [13] Few studies, however, have compared the clinical Methods -A retrospective survey was made of 279 consecutive patients with lung evaluation with the findings of transcutaneous abdominal ultrasonography, 14 15 and neither of cancer. By reviewing the patients' records the clinical findings were divided into these studies examined whether the relation ship between clinical signs and abdominal symptoms, signs, and laboratory tests indicative of metastatic disease. All patients metastases varied with the type of lung cancer.
In a recent meta-analysis of the usefulness of the had been examined by abdominal ultrasonography.
clinical examination for detecting extrathoracic metastases in lung cancer such studies are enResults -The patients included 19% with small cell carcinoma. The frequency of couraged. 16 In our Department of Thoracic Medicine we abdominal metastases by ultrasonography in those with small cell carcinoma was routinely perform transcutaneous abdominal ultrasonography on all patients with newly diag-40%, in the other patients it was 8%. Regardless of histological group, all the 40 nosed lung cancer. The objective of this study was to assess whether there is an association patients with abdominal metastases by ultrasonography had at least one clinical between clinical indicators of extensive disease and ultrasonographic signs of abdominal category indicative of widespread disease and 38 (95%) had two or all three clinical metastases in patients with lung cancer. Furthermore, we wanted to examine whether this categories positive. Fifty nine patients had no clinical indicators of metastases and relationship differed between patients with small cell and non-small cell lung cancer. none of these had abdominal metastases by ultrasonography. I  19  6  20  29  9  II  7  4  6  8  6  IIIA  20  15  24  17  24  IIIB  22  23  20  20  29  IV  33  52  29  26 32 * This group includes six patients with large cell carcinoma and four patients with carcinoid tumour.
Conclusions
change; (2) signs at clinical examination: enAbdominal ultrasonography was performed using a gray scale ultrasonograph and a sector larged lymph nodes, hepatomegaly, bone tenderness, hoarseness, superior vena cava syn-scanner of 5 MHz (GE 3000RT and GE 3600RT). In cases of insufficient penetration drome, focal neurological signs; (3) laboratory data: haemoglobin <11 g/dl, any increase in a 3.5 MHz scanner was used. The abdominal ultrasonographic examination was performed serum levels of alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), by junior and senior radiologists with ultrasonographic experience varying from a few gamma glutamyl transferase (GGT), or alkaline phosphatase (ALP). ALAT and ASAT were months to 15 years. The junior physicians were supervised by senior radiologists. considered abnormal if >50 international units (IU)/ml, GGT >100 IU/ml, and ALP >270
The differences in the presence or absence of clinical indicators of widespread disease in IU/ml. The reviews of the clinical records of the patients with and without abdominal metastases were compared by 2 analysis. Probability eligible patients were performed by three of the authors (MT, EL, GM). To examine the intra-values of less than 0.05 were considered significant. observer and inter-observer agreement of the data obtained 15 of the records were reviewed twice by each observer and 15 records were reviewed by all three without the reviewer's Results
Three hundred and nineteen patients were eliknowledge at what time during the field work this would happen. The intra-observer and gible for entry into the study. Of these, 40 were excluded either because the patient was too ill inter-observer agreement for the various symptoms and signs varied between 80% and 93%, to go through a staging or not willing to do it (n = 23), the diagnosis was made after death being lowest for focal neurological signs, headache and nausea, and highest for hepatomegaly (n = 10), there were incomplete data in the records (n = 5), or because records were missand hoarseness. However, as the presence of one symptom or sign was considered to rep-ing (n = 2).
Of the 279 patients included in the study resent an abnormality for the entire category, respectively, the inter-observer agreement when 227 (81%) were men. The mean (SD) age of the patients was 66 (13) years. Symptoms characterising the patients by category was 93%. The corresponding figure for the intra-indicating widespread disease were seen in 67% of the patients while signs of widespread disease observer agreement was 100%. The physicians who reviewed the journals were blinded to the were noted in 36%. Laboratory data indicative of abdominal metastases were noted in 41% of findings of the imaging examinations.
Histological data of the tumour and the the patients. At least one of the categories was seen in 79%, while at least two and all categories TNM classification 17 were obtained for each patient. The T and N status was based on were noted in 48% and 18% of the patients, respectively. findings of a computed tomographic (CT) examination of the thorax. The M status was, in
The distribution of patients by histological type and stage by time of diagnosis is shown addition, based on clinical findings and results of abdominal ultrasonography as well as results in table 1. The non-small cell carcinomas amounted to 81% of the lung cancers. The from brain and bone scanning. CT scanning of the thorax and abdominal ultrasonography patients with small cell carcinomas had a more advanced stage than those with non-small cell were performed on all patients, while scans of the brain and bone were made only on clinical carcinomas ( 2 = 10.41, p<0.001). Table 2 shows the frequencies of clinical suspicion of brain and bone metastases, respectively.
categories in patients with small cell carcinomas and non-small cell carcinomas. The presence The CT scans of the thorax and brain were performed with a second generation scanner of all categories was noted three times as often in the small cell carcinoma group as in the non-(GE 9800). All scans were done with an intravenous injection of contrast for better en-small cell carcinoma group. In the latter a quarter of the patients were negative to all the hancement, using a slice thickness of 1 cm. The bone scans were performed four hours after clinical categories at the time of diagnosis while only two of the patients with small cell carintravenous injection of monodiphosphate labelled with technetium-99m. Scanning was cinoma were negative to all clinical categories (table 2) . done using a gamma camera (Diacam; Siemens). The thoracic and brain CT scans and
Abdominal ultrasonography showed metastases in 19 (8%) of the 227 patients with nonthe radionuclide bone scans were interpreted by experienced physicians.
small cell carcinoma compared with 21 (40%)
group.bmj.com on May 1, 2017 -Published by http://thorax.bmj.com/ Downloaded from of the 52 with small cell carcinoma at the time of diagnosis (p<0.01). The metastatic lesions Discussion were located in the liver (n = 32), the adrenal This study describes the comparison of a deglands (n = 7), and in both liver and adrenal tailed clinical evaluation with the findings of glands (n = 1 corresponding figures for patients with nonto 100% and 79% to 100%, respectively, the small cell lung cancer vary between 8% and confidence intervals being wider due to smaller 22%. 45 8-10 14 These figures are in crude agreenumbers in the subgroups. The positive prement with those of the present study. However, dictive value of a clinical evaluation was much direct comparisons should be made with caulower than the negative predictive value, and tion. In some of the studies cited the patients was higher in those with small cell than in those were selected for entry by clinical evaluation with non-small cell carcinoma (table 4) .
indicating operable disease, 5 6 11 or by inThere was no individual clinical finding completely defined criteria. 4 8-10 In contrast, the within a category which was particularly prepresent study included consecutively all dictive of abdominal metastases. In patients patients with lung cancer, regardless of stage, with non-small cell and small cell lung cancer admitted to our department. the probability of metastatic abdominal lesions
The results of the present study agree with increased as the number of abnormal clinical those of previous surveys using isotopic categories increased (table 5) . scans [11] [12] [13] and two recent studies using abdominal ultrasonography 15 and abdominal CT scanning. 7 All these studies concluded that the result of a clinical evaluation should determine group.bmj.com on May 1, 2017 -Published by http://thorax.bmj.com/ Downloaded from is to be hoped that future studies comparing values of both methods are mainly due to difficulties in demonstrating foci of less than the clinical evaluation with various imaging techniques state precisely the criteria of the 1 cm in diameter. Ultrasonography is slightly more specific than CT scanning for liver metaclinical evaluation. Only one study detecting occult metastases defined clearly a negative stases, the figures varying between 94% and 100%, and 81% and 94%, respectively. 22 In a evaluation with respect to metastases in the liver, brain, and bone.
14 This included 146 recent study in which ultrasonography, CT scanning and MRI were compared in detecting patients with non-small cell lung cancer and compared the clinical organ status with the liver lesions, the sensitivity of MRI was in between those of CT scanning and ultrafindings of the imaging of that organ. With regard to the liver, 9% of those with a normal sonography. 25 Compared with CT scanning and MRI in the search for abdominal metaliver assessed clinically had metastases revealed by ultrasonography. In contrast, the present stases, ultrasonography has the advantage that it is an inexpensive examination without side study required a total negative clinical status, regardless of organ, to define the patient as effects and, if a potential metastasis is found, it is possible to perform a guided fine needle having an unremarkable clinical evaluation.
The rate of false positive liver metastases by aspiration directly from the tumour. 22 23 New imaging techniques such as helical CT ultrasonography is about 0-7%. 22 False positive findings may cause needless, dangerous and scanning, breath holding, and millisecond MRI and high resolution ultrasonography may intime-consuming diagnostic tests and, in the worst scenario, may prevent the patient from crease the sensitivity for abdominal metastases. 26 On the other hand, these new methods receiving a curative resection.
False negative abdominal ultrasonographic may reveal tiny nodules of less than 1 cm in diameter and it may be very difficult to decide findings occur in 30-40% of patients with abdominal metastases. 22 23 If ultrasonography is by fine needle aspiration whether or not they represent micrometastases. 26 omitted in patients with a negative clinical evaluation, additional false negative cases might Ultrasonography is less sensitive than CT scanning in detecting adrenal tumours. 27 occur. Based on our findings, these additional cases might amount to 0-6% of patients with Hence, one could argue that in the present study asymptomatic patients might have a false no markers of advanced disease. Whether this justifies routine abdominal imaging may be negative status with regard to adrenal metastases. On the other hand, in a study of 173 questioned. 16 In a recent review on the search for metastases in patients with lung cancer cost patients with lung cancer in which the clinical findings were compared with evidence of adeffectiveness analyses were requested, weighing the risk of false negative clinical evaluation renal metastases from the CT scan at the time of diagnosis the authors concluded that a CT against the problems caused by false negative imaging, false positive imaging, and the costs scan of the adrenal glands was unnecessary if the findings of a clinical examination were of routine screening. 16 The predictive values of the positive clinical normal. 7 Ultrasonography and CT scanning are categories as to the presence of abdominal metastases were higher for patients with small widely used on a routine basis in the search for metastases in patients with lung cancer. As cell carcinoma than for those with non-small cell carcinoma at the time of diagnosis. This was a consequence, one might speculate that the clinical examination may be less thorough as to be expected as the occurrence of abdominal metastases in the former histological group was the physician knows that the patients will also have a detailed imaging examination. However, much higher. For instance, in those with two abnormal categories eight of 66 patients with if the clinical evaluation of the patients with lung cancer is the basis for further search for non-small cell cancers had metastases compared with eight of 18 with small cell cancers metastases, this should restore the importance of the clinical evaluation. ( 2 = 6.68, p<0.01; table 3). The predictive value of a positive test is dependent on the true
The retrospective design of our study may have led to impaired quality of the data comprevalence of the factor being examined. 24 The positive predictive value of the clinical pared with a prospective design. The intraobserver and inter-observer agreement was evaluation was much lower than the negative predictive value (table 4). Our results indicate rather poor for some of the symptoms and clinical signs recorded from the patients' rethat ultrasonography is required to confirm the presence of metastatic disease in patients with cords. However, in the analyses the symptoms and signs were grouped into categories and the an abnormal clinical finding, but only if such a confirmation has therapeutic consequences. agreement between the categories was acceptable. Nonetheless, our findings need to be One could argue that potentially better techniques than ultrasonography, such as CT scan-confirmed by prospective studies.
In conclusion, this study indicates that a ning or magnetic resonance imaging (MRI), would be able to detect smaller metastatic le-careful clinical evaluation of patients with newly diagnosed lung cancer can identify those who sions. However, in a recent review comparing the ability of ultrasonography and CT scanning are not at risk of having abdominal metastases found on ultrasonography. Our findings into detect liver lesions, the sensitivity for CT scanning was only slightly better than for ultra-dicate that abdominal ultrasonography is not necessary in patients with a negative clinical sonography. 23 The sensitivity of the former varied between 57% and 82%, and the latter evaluation. Such a diagnostic approach in patients with lung cancer will help to rationalise between 58% and 71%. The relatively low 
